Cerepro, 250 mg/ml 4 ml 5 pcs

Cerepro is a central cholinostimulant that contains 40.5% metabolically protected choline (metabolic protection promotes the release of choline in the brain).

On entering the body it is split by the action of enzymes into choline and glycerophosphate: choline is involved in the biosynthesis of acetylcholine – one of the main mediators of neural excitation; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) of the neuronal membrane. It provides synthesis of acetylcholine and phosphatidylcholine in neuronal membranes, improves blood flow and enhances metabolic processes in the central nervous system, activates reticular formation.

It increases linear velocity of blood flow on the side of traumatic brain injury, promotes normalization of spatiotemporal characteristics of spontaneous bioelectrical activity of the brain; has a positive effect on the cognitive and behavioral responses of patients with cerebral vascular disease.

Cerepro improves brain function by acting on pathogenetic factors of involutional psycho-organic syndrome, changes phospholipid composition of neuronal membranes and reduces cholinergic activity.

Dose-dependently stimulates acetylcholine release; participating in the synthesis of phosphahydylcholine (membrane phospholipid), improves synaptic transmission, neuronal membrane plasticity, receptor function. It has no effect on the reproductive cycle and has no teratogenic and mutagenic effect.

Indications

Headache, Alzheimer’s disease, Attention and memory disorders, Mental disorders, Aggression and conflict, Acquired dementia, Stroke sequelae, Brain circulation disorders

• Acute and recovery periods of severe CMP and ischemic stroke, recovery period of hemorrhagic stroke with focal hemispheric symptoms or symptoms of brain stem damage;
• psychorganic syndrome against degenerative and involutionary changes of the brain;
• chronic insufficiency of cerebral circulation;
• cognitive disorders (disorders of thought function, memory, confusion, disorientation, reduced motivation, initiative and ability to concentrate), including.dementia and encephalopathy;
• senile pseudomelancholy.

.

Active ingredient

Choline alphoscerate

Composition

1 ml contains:

active ingredient:

glyceryl phosphorylcholine hydrate 250 mg,

auxiliary substances:

water for injection

How to take, the dosage

In acute conditions: intramuscularly or intravenously (slowly) at 1.0 g (1 ampoule) per day for 10-15 days, then switch to oral capsules at 0.8 g (2 capsules) in the morning and 0.4 g (1 capsule) during the day for 6 months.

Special Instructions

If nausea occurs after taking the drug, the dose should be reduced.

Cerepro has no effect on the speed of psychomotor reactions.

Contraindications

• hypersensitivity
• pregnancy
• breastfeeding.

.

Side effects

Allergic reactions, nausea (due to dopaminergic activation).

.

Similarities

Gliatilin, Cerepro, Cereton, Holitilin, Noocholin Rompharma, Choline alphoscerate